AdaptHealth (NASDAQ:AHCO) Lifted to “C-” at TheStreet

TheStreet upgraded shares of AdaptHealth (NASDAQ:AHCOGet Rating) from a d+ rating to a c- rating in a research report released on Tuesday, TheStreetRatingsTable reports.

Several other research analysts have also recently commented on AHCO. Truist Financial increased their target price on shares of AdaptHealth from $20.00 to $24.00 and gave the stock a buy rating in a report on Thursday, July 14th. Canaccord Genuity Group cut their price target on shares of AdaptHealth from $29.00 to $26.00 and set a buy rating for the company in a research note on Thursday, May 12th. Finally, Deutsche Bank Aktiengesellschaft cut their price target on shares of AdaptHealth from $28.00 to $22.00 in a research note on Wednesday, May 11th. Four analysts have rated the stock with a buy rating, According to data from MarketBeat, AdaptHealth currently has a consensus rating of Buy and a consensus target price of $24.67.

AdaptHealth Stock Performance

Shares of AHCO opened at $25.36 on Tuesday. AdaptHealth has a 12 month low of $11.40 and a 12 month high of $28.75. The firm has a fifty day simple moving average of $19.30 and a 200 day simple moving average of $17.35. The stock has a market capitalization of $3.41 billion, a price-to-earnings ratio of 46.11, a PEG ratio of 0.34 and a beta of 0.52. The company has a current ratio of 1.39, a quick ratio of 1.16 and a debt-to-equity ratio of 1.03.

AdaptHealth (NASDAQ:AHCOGet Rating) last announced its earnings results on Tuesday, May 10th. The company reported ($0.02) EPS for the quarter, missing the consensus estimate of $0.21 by ($0.23). AdaptHealth had a return on equity of 7.77% and a net margin of 7.54%. The business had revenue of $706.20 million for the quarter, compared to analyst estimates of $646.42 million. During the same quarter in the previous year, the company posted $0.17 EPS. The business’s revenue for the quarter was up 46.5% compared to the same quarter last year. Research analysts forecast that AdaptHealth will post 1.47 EPS for the current fiscal year.

Insider Transactions at AdaptHealth

In related news, Director Aero Holdings Ii Ll Skyknight bought 100,000 shares of the business’s stock in a transaction dated Thursday, June 16th. The stock was bought at an average price of $16.78 per share, for a total transaction of $1,678,000.00. Following the purchase, the director now owns 200,000 shares in the company, valued at approximately $3,356,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, Director Skyknight Capital Fund Ii, L.P bought 35,091 shares of the business’s stock in a transaction dated Wednesday, June 1st. The stock was bought at an average price of $17.57 per share, for a total transaction of $616,548.87. Following the purchase, the director now owns 2,929,134 shares in the company, valued at approximately $51,464,884.38. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Aero Holdings Ii Ll Skyknight acquired 100,000 shares of the company’s stock in a transaction on Thursday, June 16th. The stock was acquired at an average price of $16.78 per share, with a total value of $1,678,000.00. Following the purchase, the director now directly owns 200,000 shares in the company, valued at $3,356,000. The disclosure for this purchase can be found here. In the last 90 days, insiders purchased 350,390 shares of company stock worth $6,016,723. 17.30% of the stock is owned by insiders.

Institutional Trading of AdaptHealth

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Deerfield Management Company L.P. Series C raised its stake in AdaptHealth by 13.9% in the 1st quarter. Deerfield Management Company L.P. Series C now owns 11,650,072 shares of the company’s stock worth $186,751,000 after purchasing an additional 1,424,627 shares in the last quarter. SkyKnight Capital L.P. raised its stake in AdaptHealth by 9.3% in the 2nd quarter. SkyKnight Capital L.P. now owns 8,906,070 shares of the company’s stock worth $160,666,000 after purchasing an additional 760,499 shares in the last quarter. Vanguard Group Inc. raised its stake in AdaptHealth by 0.4% in the 1st quarter. Vanguard Group Inc. now owns 7,188,047 shares of the company’s stock worth $115,224,000 after purchasing an additional 28,749 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. raised its stake in AdaptHealth by 34.7% in the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 3,399,775 shares of the company’s stock worth $61,332,000 after purchasing an additional 876,148 shares in the last quarter. Finally, Rubric Capital Management LP raised its stake in AdaptHealth by 31.5% in the 4th quarter. Rubric Capital Management LP now owns 3,025,000 shares of the company’s stock worth $73,992,000 after purchasing an additional 725,000 shares in the last quarter. Institutional investors and hedge funds own 83.68% of the company’s stock.

AdaptHealth Company Profile

(Get Rating)

AdaptHealth Corp., together with its subsidiaries, provides home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps to patients for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.

Recommended Stories

Want More Great Investing Ideas?

Receive News & Ratings for AdaptHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AdaptHealth and related companies with MarketBeat.com's FREE daily email newsletter.